Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The FDA has approved another muscarinic receptor antagonist, after trospium, for overactive bladder.

Pharmacology Update: Darifenacin Extended-Release Tablets (Enablex)